An optimized method for enrichment of whole brain-derived extracellular vesicles reveals insight into neurodegenerative processes in a mouse model of Alzheimer's disease.
An optimized method for enrichment of whole brain-derived extracellular vesicles reveals insight into neurodegenerative processes in a mouse model of Alzheimer's disease.
复制标题
DOI:
10.1016/j.jneumeth.2018.05.022
复制
发表时间:
2018-09-01
影响因子:
3
通讯作者:
Meckes DG Jr
中科院分区:
文献类型:
--
作者:
Hurwitz SN;Sun L;Cole KY;Ford CR 3rd;Olcese JM;Meckes DG Jr
Alzheimer’s disease (AD) is the major cause of dementia in older adults, and has increased dramatically in prevalence over the past several decades. Yet many questions still surround the etiology of AD. Recently, extracellular vesicles (EVs) that transport protein, lipid, and nucleic acids from cell to cell have been implicated in the clearance and propagation of misfolded proteins. Investigation of EVs in AD progression, and their potential diagnostic utility may contribute to understanding and treating AD. However, the challenges of isolating brain-derived EVs have in part hindered these studies. Here, we provide an optimized method for the purification of brain-derived EVs by iodixanol floatation density gradient for mass spectrometry analysis. We demonstrate the purity of these vesicles and the enrichment of EV proteins compared to sedimentation gradient isolation of vesicles. Moreover, comparative proteomic analysis of brain-derived EVs from healthy and AD mouse brains revealed differences in vesicular content including proteins involved in aging, immune response, and oxidation-reduction maintenance. These changes provide insight into AD-associated neurodegeneration and potential biomarkers of AD for early disease prediction. Recent techniques have used sedimentation sucrose gradients to isolate EVs from brain tissue. However, the advantages of floatation iodixanol density gradient purification of small EVs have been reported and are further demonstrated here. Together these findings offer a rigorous technique for purifying whole tissue-derived EVs for downstream analyses, and application of this approach to uncovering molecular changes in AD progression and other neurological conditions.
登录
查看更多内容
DOI:
10.1083/jcb.200207113
发表时间:
2003-01-06
期刊:
The Journal of cell biology
影响因子:
--
作者:
Ehehalt R;Keller P;Haass C;Thiele C;Simons K
通讯作者:
Simons K
影响因子:
4.2
作者:
Dinkins MB;Dasgupta S;Wang G;Zhu G;Bieberich E
通讯作者:
Bieberich E
影响因子:
82.9
作者:
Alonso, AD;GrundkeIqbal, I;Iqbal, K
通讯作者:
Iqbal, K
影响因子:
4.8
作者:
Jiang, RF;Gao, BC;Eisenberg, E
通讯作者:
Eisenberg, E
影响因子:
5.4
作者:
Hurwitz, Stephanie N.;Nkosi, Dingani;Meckes, David G., Jr.
通讯作者:
Meckes, David G., Jr.